NCT05158374 2025-02-06
Molecular Effects of Aspirin & Metformin on Colonic Epithelium
University of Edinburgh
Phase NA Withdrawn
Clinical Trials
13 trialsNCT03047837 2025-01-27
ASAMET
Ente Ospedaliero Ospedali Galliera
Phase 2 Terminated
NCT03800602 2024-09-05
Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer
Emory University
Phase 2 Completed
NCT05921942 2024-02-02
The Impact of Metformin Administration on the Clinical Outcome of Stage IV Colon Cancer
Ain Shams University
Phase 3 Completed
NCT04033107 2023-09-28
High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors
Zhongnan Hospital
Phase 2 Unknown
NCT01312467 2019-03-05
Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI
National Cancer Institute (NCI)
Phase 2 Completed
NCT01523639 2018-12-19
G-LUCAS
Austrian Breast & Colorectal Cancer Study Group
Phase 2 Terminated
NCT01340300 2018-06-06
Exercise and Metformin in Colorectal and Breast Cancer Survivors
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01926769 2018-05-15
A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer
Gachon University Gil Medical Center
Phase 2 Terminated
NCT01930864 2017-06-22
Metformin Plus Irinotecan for Refractory Colorectal Cancer
Barretos Cancer Hospital
Phase 2 Unknown
NCT01632020 2016-07-11
Effect of Metformin on Biomarkers of Colorectal Tumor Cell Growth
University of Arkansas
Phase 2 Terminated
NCT01816659 2015-11-18
An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT01941953 2015-04-08
Metformin and 5-fluorouracil for Refractory Colorectal Cancer.
Instituto do Cancer do Estado de São Paulo
Phase 2 Completed